Cyclosporin immunosuppression of sheep: Pharmacokinetics and allograft survival

Veterinary Immunology and Immunopathology

Volumn 81, Issue 1-2, 2001, Pages 23-36

  Rose, A H ^a   Ilett, K F ^a   O'Donoghue, H L ^a   Hackett, L P ^a   Penhale, W J ^a   Manning, L S ^a   Glancy, R J ^a   Cullen, L K ^a   Turner, J H ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Allografts; Cyclosporin; Immunosuppression; Ketoconazole; Sheep

Indexed keywords

CYCLOSPORIN A; KETOCONAZOLE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; GRAFT SURVIVAL; HEMATOLOGY; HISTOLOGY; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PLASMA; SHEEP; SKIN ALLOGRAFT; STEADY STATE;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; FEMALE; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; KETOCONAZOLE; SHEEP; SKIN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

OVIS ARIES;

EID: 0035975162     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(01)00324-5     Document Type: Article

References (23)

1. Pharmacology of cyclosporine (Son dimmune). IV. Pharmacological properties in vivo
2. Pharmacokinetics and absolute bioavailability of cyclosporin following intravenous and abomasal administration to sheep
3. Metabolism of cyclosporin A: purification and identification of the rifampicin inducible human liver cytochrome P-450 (cyclosporin A oxidase) as a product of the P450IIIA gene family
4. Comparison of cyclosporine measurements in whole blood by hugh performance liquid chromatography, monoclonal fluorescence polarization immunoassay, and monoclonal enzyme multiplied immunoassay
5. Cyclosporine-ketoconazole interaction. Long-term follow-up and preliminary results of a randomized trial
6. The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine
7. Ketoconazole to reduce the need for cyclosporine after cardiac transplantation
8. Cyclosporine pharmacology
9. Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture
10. Factors affecting plasma levels of ketoconazole during long-term treatment
11. Cyclosporine. A immunosuppression in sheep with response enhancement by concomitant ketoconazole
12. Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in clinical chemistry, Part II
13. A preliminary report of diltiazem and ketoconazole. Their cyclosporine-sparing effect and impact on transplant outcome
14. Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporinA oxidase) in primary cultures of human hepatocytes and in liver microsomes
15. Identification of the rabbit and human cytochrome P-450IIIA as the major enzymes involved in the N-demethylation of diltiazem
16. Clinical and medicoeconomic impact of the cyclosporine-diltiazem interaction in renal transplant recipients
17. Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy
18. Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation
19. Diltiazem treatment with reduced dose of cyclosporine in renal transplant recipients
20. The haemodynamic effects of cyclosporin A in sheep